AU2002220920A1 - Method for identification of genes involved in specific diseases - Google Patents
Method for identification of genes involved in specific diseasesInfo
- Publication number
- AU2002220920A1 AU2002220920A1 AU2002220920A AU2092002A AU2002220920A1 AU 2002220920 A1 AU2002220920 A1 AU 2002220920A1 AU 2002220920 A AU2002220920 A AU 2002220920A AU 2092002 A AU2092002 A AU 2092002A AU 2002220920 A1 AU2002220920 A1 AU 2002220920A1
- Authority
- AU
- Australia
- Prior art keywords
- identification
- genes involved
- specific diseases
- diseases
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0030076A GB0030076D0 (en) | 2000-12-08 | 2000-12-08 | Analysis method |
GB0030076.4 | 2000-12-08 | ||
GB0103156.6 | 2001-02-08 | ||
GB0103156A GB0103156D0 (en) | 2001-02-08 | 2001-02-08 | Analysis method |
GB0125666A GB0125666D0 (en) | 2001-10-25 | 2001-10-25 | Analysis method |
GB0125666.8 | 2001-10-25 | ||
PCT/GB2001/005458 WO2002046465A2 (en) | 2000-12-08 | 2001-12-10 | Method for identification of genes involved in specific diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002220920A1 true AU2002220920A1 (en) | 2002-06-18 |
Family
ID=27255999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002220920A Abandoned AU2002220920A1 (en) | 2000-12-08 | 2001-12-10 | Method for identification of genes involved in specific diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002220920A1 (en) |
WO (1) | WO2002046465A2 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002078729A1 (en) | 2001-03-29 | 2002-10-10 | Celltech R & D, Inc. | Compositions and methods for diagnosing or treating psoriasis |
JPWO2003044197A1 (en) * | 2001-11-21 | 2005-03-24 | 独立行政法人科学技術振興機構 | Huntington's disease gene transcription factor |
WO2003073823A2 (en) | 2002-03-01 | 2003-09-12 | Exelixis, Inc. | PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
WO2004012817A2 (en) * | 2002-07-31 | 2004-02-12 | Kylix B.V. | Use of genes identified to be involved in tumor development for the development of anti-cancer drugs |
MXPA05004134A (en) * | 2002-10-18 | 2005-10-05 | Atugen Ag | Factor involved in metastasis and uses thereof. |
AU2003291136A1 (en) * | 2002-11-21 | 2004-06-18 | The General Hospital Corporation | Redd1, a transcriptional target of p63 and p53, and methods of use therefor |
WO2004048928A2 (en) | 2002-11-25 | 2004-06-10 | The United States Of America As Represented By The Secretary Of Health And Human Services, Nih | Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array |
WO2004058817A1 (en) * | 2002-12-26 | 2004-07-15 | Takeda Pharmaceutical Company Limited | Novel proteins and use thereof |
WO2004111641A2 (en) * | 2003-06-12 | 2004-12-23 | University Of Manitoba | Methods for detecting cancer and monitoring cancer progression |
SE0302122D0 (en) * | 2003-07-22 | 2003-07-22 | Astrazeneca Ab | Genetic marker |
AU2004298604B2 (en) * | 2003-12-15 | 2010-09-23 | The Regents Of The University Of California | Molecular signature of the PTEN tumor suppressor |
EP1712619A4 (en) * | 2003-12-24 | 2008-01-02 | Takeda Pharmaceutical | Preventive/remedy for cancer |
WO2005111239A2 (en) * | 2004-04-30 | 2005-11-24 | Decode Genetics Ehf. | Haplotypes in the human thioredoxin interacting protein homologue (arrdc3) gene associated with obesity |
JPWO2005118631A1 (en) | 2004-06-03 | 2008-05-29 | 武田薬品工業株式会社 | Novel protein complex and its use |
WO2005123955A2 (en) * | 2004-06-09 | 2005-12-29 | Children's Medical Center Corporation | Methods and compositions for modifying gene regulation and dna damage in ageing |
KR101094617B1 (en) | 2004-08-16 | 2011-12-15 | 사일런스 테라퓨틱스 아게 | Therapeutic uses of inhibitors of rtp801 |
US7825099B2 (en) | 2006-01-20 | 2010-11-02 | Quark Pharmaceuticals, Inc. | Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes |
DOP2007000015A (en) | 2006-01-20 | 2007-08-31 | Quark Biotech Inc | THERAPEUTIC USES OF RTP801 INHIBITORS |
US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
EP3168618B1 (en) | 2006-04-04 | 2018-11-21 | Singulex, Inc. | Highly sensitive methods for analysis of troponin |
US7723052B2 (en) | 2006-05-11 | 2010-05-25 | Quark Pharmaceuticals, Inc. | Screening systems utilizing RTP801 |
EP2026843A4 (en) | 2006-06-09 | 2011-06-22 | Quark Pharmaceuticals Inc | Therapeutic uses of inhibitors of rtp801l |
US8158356B2 (en) | 2006-10-16 | 2012-04-17 | Agrigenomics, Inc. | Screening for the genetic defect causing tibial hemimelia in bovines |
EP2137205A2 (en) | 2007-02-26 | 2009-12-30 | Quark Pharmaceuticals, Inc. | Inhibitors of rtp801 and their use in disease treatment |
JP2010520333A (en) | 2007-03-01 | 2010-06-10 | セダーズ−シナイ メディカル センター | Antioxidant polymer containing [1,2] -dithiolane moiety and use thereof |
US8614311B2 (en) | 2007-12-12 | 2013-12-24 | Quark Pharmaceuticals, Inc. | RTP801L siRNA compounds and methods of use thereof |
WO2009086547A1 (en) | 2008-01-03 | 2009-07-09 | Cedars-Sinai Medical Center | Antioxidant nanosphere comprising [1,2]-dithiolane moieties |
EP2300451A1 (en) | 2008-06-02 | 2011-03-30 | Cedars-Sinai Medical Center | Nanometer-sized prodrugs of nsaids |
ES2529060T3 (en) | 2008-11-24 | 2015-02-16 | Cedars-Sinai Medical Center | Antioxidant derivatives of camptothecin and antioxidant antineoplastic nanospheres thereof |
WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
US8431346B2 (en) | 2009-12-18 | 2013-04-30 | Agrigenomics, Inc. | Screening for arthrogryposis multiplex in bovines |
GB2493540A (en) * | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
CA2760873C (en) | 2011-12-02 | 2020-04-21 | Sabine Mai | Diagnostic methods for hematological disorders |
EP3294886A4 (en) | 2015-05-11 | 2019-02-20 | Mimetics, LLC | Methods for identifying targets for antimicrobial and antiproliferative compounds and compositions therefrom |
-
2001
- 2001-12-10 AU AU2002220920A patent/AU2002220920A1/en not_active Abandoned
- 2001-12-10 WO PCT/GB2001/005458 patent/WO2002046465A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002046465A2 (en) | 2002-06-13 |
WO2002046465A3 (en) | 2003-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002220920A1 (en) | Method for identification of genes involved in specific diseases | |
AU2001234608A1 (en) | Methods for analysis of gene expression | |
AU2002306849A1 (en) | Identification of essential genes in microorganisms | |
AU6611900A (en) | Techniques for facilitating identification of candidate genes | |
AU2001279683A1 (en) | Biosensor and method for production thereof | |
AU2001278783A1 (en) | Method of amplifying nucleic acid | |
AU2745000A (en) | Method for nucleic acid isolation and kit | |
AU2002232393A1 (en) | Methods for identifying genes associated with diseases or specific phenotypes | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU2001268467A1 (en) | Identification of genes and compounds for treatment of cancer | |
AU2001257903A1 (en) | Method for treatment of neurodegenerative diseases | |
AU2002214286A1 (en) | Method of profiling protein | |
AU2002218417A1 (en) | Nucleic acid extraction method and kit | |
AU2002222618A1 (en) | Method of analyzing gene expression | |
AU2001296015A1 (en) | Method of synthesizing single-stranded nucleic acid | |
AU2002301109A1 (en) | Method for the prediction of preeclampsia and other diseases | |
AU2001287268A1 (en) | Method of identifying inhibitors of tie-2 | |
AU2001262152A1 (en) | Method for extracting nucleic acids | |
AU2001269077A1 (en) | Methods and means for regulation of gene expression | |
AU2001247676A1 (en) | Methods for in vivo diversification of single genes | |
AU2002221104A1 (en) | Method of detecting relation between genes | |
AU2001257427A1 (en) | Rna metabolism proteins | |
AU2002221638A1 (en) | Method for establishing germ cell-specific gene expression | |
AU2001293710A1 (en) | System and method for operation-integrated user identification | |
AU2001292468A1 (en) | Methods and means of rna analysis |